Ignite Creation Date:
2024-05-06 @ 8:10 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06277154
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-26
First Post:
2024-02-02
Brief Title:
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
Sponsor:
HRYZ Biotech Co
Organization:
HRYZ Biotech Co
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-02
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-02
First Submit QC Date:
February 17 2024
Study First Post Date:
2024-02-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-17
Last Update Post Date:
2024-02-26
Last Update Post Date Type:
ACTUAL